We previously demonstrated that myeloid BMAL1 protects against lipopolysaccharide (LPS) induced lethality (23), and that BMAL1 maintains an anti-inflammatory environment during experimental autoimmune encephalomyelitis (EAE), a mouse CNS autoimmune disease model (24). The gene discussed is BMAL1; the disease is experimental autoimmune encephalomyelitis.